HeraMED has accepted a $1.02m private placement from three leading institutional investors to advance its growth strategy. ..
The securities to be issued pursuant to the private placement, and any Warrant Shares to be issued on the exercise of Warrants will be subject to a four-month statutory hold period. The Company ...